Skip to main content
Elsevier Sponsored Documents logoLink to Elsevier Sponsored Documents
. 2016 Aug;55:53–64. doi: 10.1016/j.lmot.2016.06.001

The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials

MA Pezze 1, HJ Marshall 1, HJ Cassaday 1,
PMCID: PMC4974238  PMID: 27524835

Abstract

In an appetitively motivated procedure, we have previously reported that systemic treatment with the dopamine (DA) D1 receptor agonist SKF81297 (0.4 and 0.8 mg/kg) depressed acquisition at a 2 s inter-stimulus-interval (ISI), suitable to detect trace conditioning impairment. However since DA is involved in reinforcement processes, the generality of effects across appetitively- and aversively-motivated trace conditioning procedures cannot be assumed. The present study tested the effects of SKF81297 (0.4 and 0.8 mg/kg) in an established conditioned emotional response (CER) procedure. Trace-dependent conditioning was clearly shown in two experiments: while conditioning was relatively strong at a 3-s ISI, it was attenuated at a 30-s ISI. This was shown after two (Experiment 1) or four (Experiment 2) conditioning trials conducted in – as far as possible – the same CER procedure. Contrary to prediction, in neither experiment was there any indication that trace conditioning was attenuated by treatment with 0.4 or 0.8 mg/kg SKF81297. In the same rats, locomotor activity was significantly enhanced at the 0.8 mg/kg dose of SKF81297. These results suggest that procedural details of the trace conditioning variant in use are an important determinant of the profile of dopaminergic modulation.

Keywords: Dopamine D1, Trace conditioning, Contextual conditioning, Rat, SKF81297

1. Introduction

Pavlovian trace conditioning procedures require the acquisition of an association between a conditioned stimulus (CS, e.g. noise) and an unconditioned stimulus (US, e.g. food or foot shock) despite the interposition of an interval of time between these events (Pavlov, 1927). The ability to condition to the trace of the CS when it is no longer present allows animals to form associations when events, which may nonetheless be causally-related, are separated in time. By definition, trace conditioning procedures test working memory defined as the capacity to maintain ‘on line’ transitory information (Goldman-Rakic, 1996). Such working memory is likely essential for associative processes in general, and in particular when a time interval must be bridged (Gilmartin, Balderston, & Helmstetter, 2014). Hence trace conditioning is widely used to investigate the neural substrates of this important aspect of working memory (Cassaday, Nelson, & Pezze, 2014).

The dominant paradigm used to study trace conditioning is eye blink conditioning in the rabbit which is known to rely on interactions between medial pre-frontal cortex (mPFC) and cerebellum (Kalmbach, Ohyama, Kreider, Riusech, & Mauk, 2009). Cerebellum may not be necessary for trace conditioning in other task variants and in any case it is important to test the generality of findings. Moreover, eye blink procedures typically use a very short trace or inter-stimulus-interval (ISI). We have therefore developed task variants suitable to examine trace conditioning over longer ISIs than the ms intervals typical of eye blink conditioning procedures.

In an appetitively motivated procedure, we have previously reported that systemic treatment with the dopamine (DA) D1 receptor agonist SKF81297 (0.4 and 0.8 mg/kg) depressed acquisition at a 2-s inter-stimulus-interval (ISI), suitable to detect trace conditioning impairment (Pezze, Marshall, & Cassaday, 2015). There was no effect on trace conditioning over the 10-s interval which was included to test for trace conditioning enhancement. This finding was counter to expectation in that systemic amphetamines reliably increase conditioning over a trace interval (Horsley and Cassaday, 2007, Norman and Cassaday, 2003). One possibility is that the motivation of the trace conditioning variant in use is an important determinant of the profile of dopaminergic modulation.

The conditioned emotional response (CER: noise → foot shock) procedures used in the present study are well established (Cassaday, Horsley, & Norman, 2005; Cassaday, Shilliam, & Marsden, 2001; Grimond-Billa, Norman, Bennett, & Cassaday, 2008; Horsley & Cassaday, 2007; Nelson, Thur, Spicer, Marsden, & Cassaday, 2011; Norman & Cassaday, 2003). These same procedures are sensitive to the effects of indirect DA agonists (systemically administered amphetamines: Horsley and Cassaday, 2007, Norman and Cassaday, 2003), as well as catecholaminergic depletion in nucleus accumbens (Nelson et al., 2011). Dopaminergic mechanisms are clearly involved in both appetitive (Dalley et al., 2002) and aversive conditioning (Feenstra, Vogel, Botterblom, Joosten, & de Bruin, 2001; Lauzon, Bechard, Ahmad, & Laviolette, 2013; Pezze & Feldon, 2004; Pezze, Bast, & Feldon, 2003). However, comparing across appetitive and aversive trace conditioning variants, there is evidence pointing to some differences in the underlying mechanisms (Cassaday et al., 2005).

Motivational valence inevitably affects other procedural parameters in that foot shock is more salient than food reward and salience is an important determinant of associative leaning. Many more learning trials are used in appetitive than is necessary or desirable in aversive procedures. In itself, the number of learning trials may also be a critical parameter in that a higher number of learning trials affords additional opportunity for consolidation, as well as an extended period of consolidation to the extent the duration of the conditioning session is increased along with the number of trials (Da Silva, Bast, & Morris, 2015; Domjan, 1980; Genoux, Haditsch, Knobloch, Michalon, Storm et al., 2002; McGaugh, Cahill, & Roozendaal, 1996). In CER procedures conducted at lower foot shock intensities, a greater number of pairings may result in a comparable level of conditioning to that typically seen after two pairings at higher foot shock intensity (Norman & Cassaday, 2003). Therefore, in the present study, we also used an increased numbers of pairings to promote consolidation, at a lower foot shock intensity to match – as far as possible – the baseline level of conditioned fear. Specifically, we compared the effects of SKF81297 (0.4 and 0.8 mg/kg) on trace conditioning conducted in a CER procedure using two (Experiment 1) or four (Experiment 2) pairings of a noise CS with foot shock, set at 1 mA (Experiment 1) or 0.5 mA (Experiment 2). In both experiments, we examined the effects of SKF81297 at 3-s and 30-s trace intervals which are suitable to test for impaired and enhanced trace CER conditioning, respectively. Thus we sought to examine the generality of the previous finding of impaired (short) trace conditioning obtained with SKF81297 in an appetitive procedure (Pezze, Marshall, & Cassaday, 2015) while including a longer trace suitable to test for trace conditioning enhancement (Horsley and Cassaday, 2007, Norman and Cassaday, 2003). Finally, the drug naïve (vehicle-injected) rats tested in Experiment 2 were subsequently used to examine the effects of the same doses of SKF81297 on locomotor activity (LMA) by way of positive control.

2. Materials and methods

2.1. Subjects

Seventy-two experimentally naïve adult male Wistar rats (Charles River, UK) were used for each experiment. They were caged in groups of four, in individually ventilated cages (IVCs) on a 12:12 h light/dark cycle with food and water ad libitum. After arrival, each rat was handled daily for one week and placed on water restriction 24 h prior to the start of each experiment. The mean start weight was 220 g (range 196–239 g) in Experiment 1 and 212 g (range 191–246 g) in Experiment 2. All procedures were conducted in accordance with the UK Animal Scientific Procedures Act 1986, Project Licence numbers: PPL 40/3163 (Experiment 1) and PPL 40/3716 (Experiment 2).

2.2. Drug treatments

SKF81297 (Tocris, UK) was dissolved in saline (0.9% NaCl) to provide an injectable volume of 1 ml/kg at doses of 0.4 mg/kg and 0.8 mg/kg. Drug doses were based on previous studies run in our laboratory (Nelson, Thur, & Cassaday, 2012; Pezze, Marshall, & Cassaday, 2015). In both experiments, vehicle (saline) or SKF81297 (0.4 mg/kg or 0.8 mg/kg) were injected subcutaneously (s.c.) 15 min prior to the conditioning stage of the trace conditioning procedure. The same treatments were further examined in LMA.

2.3. Trace conditioning apparatus

Both experiments were conducted using 6 duplicate fully automated conditioning chambers (Cambridge Cognition, Cambridge, UK), housed within sound-attenuating cases fitted with ventilation fans. The conditioning boxes were made of plain steel (25 cm × 25 cm × 22 cm high) with a Plexiglas door (19 cm × 27 cm) inset at the front. A waterspout was mounted on one wall, 5 cm above the floor and connected to a lickometer supplied by a pump. The number of licks made was registered by a break in the photo beam within the waterspout, which also triggered the delivery of water (0.05 ml per lick). The waterspout was illuminated when water was available. A loudspeaker set in the roof of each conditioning box produced the CS (tone), which consisted of a 5-s mixed frequency noise set at 85 dB (including background); this was presented at either 3-s or 30-s trace intervals before the US (foot shock). The foot shock of 1 s duration set at 1 mA (Experiment 1) or 0.5 mA intensity (Experiment 2) provided the US. This shock was delivered through the grid floor (steel bars 1 cm apart) by a constant current shock generator (pulsed voltage: output square wave 10 ms on, 80 ms off, 370 V peak under no load conditions; MISAC Systems, Newbury, UK). Three wall-mounted stimulus lights and the house light were set to flash on (0.5 s) and off (0.5 s) for the duration of the conditioning session, thus providing an experimental background stimulus. Stimulus control and data collection were performed by an Acorn Archimedes RISC computer programme in Basic with additional interfacing using an Arachnid extension (Cambridge Cognition).

2.4. LMA apparatus

Twelve clear Perspex chambers (39.5 cm long × 23.5 cm wide × 24.5 cm deep) with metal grid lids were used (Photobeam Activity System, San Diego Instruments, USA). The chambers were surrounded by frames containing two levels of photobeams as described previously (Jones, Brown, Auer, & Fone, 2011; Pezze, McGarrity, Mason, Fone, & Bast, 2014; Pezze, Marshall, Fone, & Cassaday, 2015). Two consecutive breaks of adjacent beams within the lower level of photobeams generated a locomotor count. The apparatus was situated in a dimly lit (50-70 lx) room. To start a session, rats were placed into the centre of the chamber. Total locomotor counts were recorded for each consecutive 10-min epoch, for 30 min pre-treatment and 60 min post-treatment.

2.5. Behavioural conditioning procedure

Water restriction was introduced 1 day prior to shaping. The rats received 1 h ad libitum access to water in their home cages after each of the procedural stages described below. This home cage access was in addition to any water drunk in the conditioning boxes (available from the apparatus waterspout on all days of the procedure apart from the conditioning day). Therefore the rats were trained, conditioned and tested in counterbalanced groups of six after 20–23 h of water restriction.

2.5.1. Pre-conditioning to establish baseline lick response

In order to initiate licking behaviour, rats were shaped over two days. On the first day, rats were placed in the conditioning boxes in pairs (with their cage mates), where they were given one or more 15-min sessions to learn how to drink from the illuminated waterspout. On the second day of shaping, they were individually allocated to a conditioning box to ensure that all rats were independently drinking freely. Thereafter, the rats were assigned to their individual boxes for the duration of the experiment (counterbalanced by experimental group). No data were recorded.

Five days of pre-training followed, in which rats drank for 15 min each day (timed from first lick). The waterspout was illuminated throughout, but no other stimuli were present in this phase. The latency to first lick was measured as an indicator of habituation to the experimental context. In addition the total number of licks was also analysed to assess any pre-existing differences in baseline drinking (prior to conditioning).

2.5.2. Conditioning with foot shock

The waterspouts were not illuminated and no water was available during the conditioning session. The US (foot shock) was delivered following the termination of the CS (tone) at either 3-s or 30-s trace intervals. There were two pairings of CS and US in Experiment 1 and four pairings of CS and US in Experiment 2. The flashing light experimental background stimulus was presented for the duration of the conditioning session. In Experiment 1, the first pairing of CS and US was presented after 5 min had elapsed, and the second pairing was 5 min after the first, followed by a further 5 min spent in the apparatus. The same procedure was used in Experiment 2 with two additional CS and US pairings (totalling four). The first pairing was presented after 5 min had elapsed, with the following three pairings presented at 5-min intervals followed by a further 5 min spent in the apparatus. In the absence of licking, no behavioural measures were recorded.

2.5.3. Re-shaping after foot shock

In order to re-establish drinking behaviour after conditioning, rats were re-shaped the following day. This followed the same procedure used in the pre-conditioning, in which rats drank for 15 min (timed from first lick). Conditioning to the box context was measured as the latency to first lick, as well as the profile of drinking over the 15 min session.

2.5.4. Test

Conditioned suppression to the experimental stimuli was tested on two consecutive days following re-shaping. Rats were placed in the conditioning boxes and presented with the CS (tone) on day 1 and the background stimulus (light) on day 2. Water was available throughout the test and the waterspout was illuminated. After the rats had made 50 licks, the stimulus tone (day 1) or light (day 2) was presented for 15 min. The time taken to make the first 50 licks in the absence of any stimulus (the A period) provided a measure of any individual variation in baseline lick responding. This was compared with the time taken to complete 50 licks following stimulus onset (the B period) in a suppression ratio (A/(A + B)) to determine the level of conditioning to either stimulus, adjusted for any individual baseline variation. The profile of drinking over the 15 min session provided an additional measure of conditioned suppression.

2.6. LMA procedure

This was tested two replications, each of 12 rats from the vehicle-injected group of Experiment 2. Due to the malfunction of one of the activity chambers, data from two of the available rats was not collected. One day before the drug tests, each rat was placed in a test chamber for 30 min to habituate it to the box. The habituation activity data were also used to match the rats’ allocation to drug groups (so that there were no differences in baseline activity). On the following day, rats were replaced in the same test chamber for 30 min to achieve further habituation and to facilitate the detection of any SKF81297-induced LMA. Rats were then subcutaneously injected with saline, or 0.4 or 0.8 mg/kg of SKF81297 and immediately replaced in their allocated activity boxes for 60 min.

2.7. Experimental design and analysis

In both experiments, there were six experimental groups run in a 2 × 3 independent factorial design. The between subject factors were trace at levels 3 s or 30 s and drug at doses saline or SKF81297 (0.4 mg/kg or 0.8 mg/kg). The dependent variables to check for differences by experimental condition-to-be were pre-conditioning drink latencies and the number of licks made during the 15-min pre-conditioning session. Contextual conditioning to the box cues was measured by the reshaping drink latencies and the number of licks made during the 15-min reshaping session. On each of the test days, the level of conditioning to the CS or the experimental background stimulus was measured by the suppression ratios and the number of licks made during the 15-min test session. The licks analyses were run in a mixed design with the repeated measures factor of min which had 15 levels. In the case of significant interactions with min, follow up ANOVA was restricted to the first 60 s of drinking (min 1) which typically shows the closest correspondence with the pattern of effects shown on the suppression ratios at relatively low levels of suppression. Figs. 1 and 2 show suppression ratios and min 1 licks for the noise tests of both experiments, to allow direct comparison. The locomotor effects of SKF81297 were tested in mixed design with drug as the between-subjects factor and 10 min blocks of activity counts as the within-subjects factor. Follow up ANOVAs by individual block were conducted to explore the interaction. Where required, post hoc tests were performed by Fisher’s LSD test.

Fig. 1.

Fig. 1

Effects on conditioning of the D1 receptor agonist SKF81297 at 0 (white columns), 0.4 (grey columns), and 0.8 (black columns) mg/kg in Experiment 1. The error bars show the standard error of the mean (n = 9-12/group). Tests were conducted drug-free after prior conditioning under drug conducted with two CS (noise) → US (1 mA shock) pairings, presented using either a 3-s or 30-s trace interval. A. Suppression to the experimental chambers: the level of contextual conditioning is expressed as mean latency to make the first lick (s). B. Conditioned suppression to the noise CS expressed as the mean suppression ratio. C. Conditioned suppression to the noise CS measured as the number of licks in the first min of test presentation. D. Conditioned suppression to the light background expressed as the mean suppression ratio.

In Experiment 1, the data of ten rats were excluded from the light test analyses, because of equipment failure on the light test day. This left a final sample size of 62 (n = 9-12/cell). Three rats’ data were excluded in Experiment 2, due to equipment failure on the noise test day. This left a final sample size of 69 (n = 10-12/cell). Two rats’ data were missing from the LMA analyses, leaving a final sample size of 22 (n = 7-8/cell).

3. Results

3.1. Experiments 1 with 2 conditioning trials

3.1.1. Pre-conditioning—baseline licking

There were no effects of drug, F(2,66) = 1.968, p = 0.148, or trace condition-to-be, F < 1, on the latency to start drinking on the final pre-conditioning day. This confirms that the rats’ drinking was well-matched prior to any conditioning. An ANOVA performed on the number of licks made over the 15-min session showed the expected main effect of min, F(14,924) = 109.126, p < 0.0001. However, the decline in drinking over the course of the session was uninfluenced by drug, F(28,924) = 1.175, p = 0.244, or trace condition-to-be, F(14,924) = 1.189, p = 0.278 (data not shown).

3.1.2. Reshaping—contextual conditioning

On the reshaping day there was no statistical evidence for any effect of prior drug or trace condition on the level of drinking at the start of the session (Fig. 1A). There was no difference in the latency to first drink by drug or trace, nor any interaction between these factors, all Fs <1. There was a main effect of min on the number of licks made over the 15 min session, F(14,924) = 72.639, p < 0.0001. However, there was no effect of drug by min, F(28,924) = 0.633, p = 0.931, or trace by min, F(14,924) = 1.225, p = 0.251 (Table 1A). There was some suggestion that drug treatment at conditioning had some influence on contextual conditioning in that there was a min × drug × trace interaction, F(28,924) = 1.613, p = 0.024, but there was no effect by drug on the min 1 measure, both Fs < 1.

Table 1.

Licking behaviour over the 15 min sessions conducted at (A) reshaping, (B) the noise test and (C) the light test subsequent to treatment with the D1 receptor agonist SKF81297 (SKF) at 0, 0.4 and 0.8 mg/kg in Experiment 1. The table shows the mean number of licks made in each min ± the standard error of the mean. Tests were conducted drug-free after prior conditioning under SKF conducted with two CS (noise) → US (1 mA shock) pairings, presented using either a 3 s or 30 s trace interval.

A. Reshaping
Trace 3 s 30 s
Drug Sal 0.4
SKF
0.8 SKF Sal 0.4 SKF 0.8
SKF
Min
1 202.750 ± 28.239 226.333 ± 24.863 211.000 ± 14.960 227.333 ± 16.627 208.500 ± 28.332 219.833 ± 20.827
2 191.667 ± 20.791 207.000 ± 23.583 185.083 ± 17.194 169.333 ± 20.409 147.583 ± 19.085 163.667 ± 13.017
3 163.083 ± 24.823 163.250 ± 14.691 155.333 ± 18.246 165.417 ± 21.496 167.667 ± 19.248 165.750 ± 16.945
4 144.833 ± 25.087 129.250 ± 24.038 126.083 ± 21.704 154.917 ± 25.805 138.500 ± 19.927 141.833 ± 23.522
5 121.333 ± 26.173 192.000 ± 19.897 116.333 ± 23.667 150.667 ± 26.655 127.333 ± 18.162 138.333 ± 13.796
6 108.167 ± 27.579 137.583 ± 23.341 74.083 ± 20.020 166.750 ± 20.307 101.083 ± 19.558 148.000 ± 25.575
7 132.667 ± 26.060 48.083 ± 12.852 121.500 ± 27.200 111.000 ± 25.445 120.000 ± 21.759 86.833 ± 16.878
8 73.000 ± 23.584 54.167 ± 17.281 34.083 ± 12.277 83.667 ± 31.328 39.000 ± 15.216 87.000 ± 23.460
9 66.917 ± 22.640 51.333 ± 18.054 47.500 ± 22.368 54.083 ± 20.973 63.833 ± 22.967 70.167 ± 28.729
10 54.333 ± 21.091 32.750 ± 16.474 76.000 ± 23.739 64.083 ± 25.222 47.500 ± 13.996 40.667 ± 13.293
11 62.000 ± 18.182 39.167 ± 13.439 12.333 ± 6.922 58.083 ± 23.147 21.583 ± 15.558 64.333 ± 23.410
12 31.250 ± 21.437 26.667 ± 11.683 35.500 ± 15.895 30.500 ± 12.321 37.500 ± 17.502 54.833 ± 26.808
13 39.250 ± 15.893 54.500 ± 25.917 26.000 ± 14.404 4.000 ± 3.645 23.917 ± 9.672 9.167 ± 5.396
14 43.250 ± 20.096 12.417 ± 8.196 24.250 ± 12.437 16.500 ± 9.902 29.250 ± 12.464 27.917 ± 9.460
15 42.417 ± 18.947 21.083 ± 15.0200 6.917 ± 6.826 12.500 ± 10.826 36.500 ± 8.609 51.917 ± 24.811
B. Noise test
Trace 3 s 30 s
Drug Sal 0.4
SKF
0.8
SKF
Sal 0.4 SKF 0.8
SKF
Min
1 20.667 ± 10.357 22.833 ± 12.567 56.583 ± 17.261 113.000 ± 25.138 130.333 ± 22.662 135.917 ± 24.542
2 62.250 ± 26.232 70.083 ± 30.160 131.417 ± 27.623 161.000 ± 27.908 177.500 ± 8.593 207.167 ± 18.356
3 93.167 ± 29.525 95.250 ± 29.600 150.000 ± 27.924 125.000 ± 19.271 159.583 ± 19.064 201.333 ± 19.806
4 122.333 ± 30.279 101.500 ± 29.968 159.250 ± 28.873 167.167 ± 21.338 172.083 ± 13.284 144.917 ± 17.890
5 111.250 ± 23.638 120.667 ± 32.568 177.750 ± 29.103 143.167 ± 26.263 114.417 ± 16.963 132.333 ± 27.089
6 136.167 ± 22.669 113.000 ± 26.581 126.917 ± 20.100 85.750 ± 20.902 119.667 ± 21.371 134.833 ± 23.732
7 111.167 ± 31.156 136.000 ± 25.675 124.667 ± 33.330 118.417 ± 21.351 55.583 ± 15.986 78.917 ± 21.097
8 98.833 ± 28.623 124.750 ± 30.004 67.917 ± 23.152 124.167 ± 32.047 73.167 ± 19.793 103.250 ± 23.897
9 117.667 ± 27.052 119.917 ± 26.733 116.917 ± 23.382 83.500 ± 24.872 105.500 ± 22.889 58.250 ± 22.364
10 98.083 ± 27.136 127.167 ± 22.489 112.583 ± 26.639 70.417 ± 23.219 66.750 ± 13.694 51.417 ± 14.176
11 63.667 ± 19.800 78.917 ± 28.806 46.083 ± 12.348 54.000 ± 20.892 29.167 ± 10.551 51.750 ± 21.620
12 47.667 ± 21.513 89.500 ± 18.017 59.167 ± 18.739 33.750 ± 13.778 42.750 ± 13.979 17.500 ± 8.957
13 70.000 ± 21.302 93.250 ± 20.240 62.000 ± 17.447 39.167 ± 19.459 25.750 ± 12.260 6.833 ± 4.846
14 33.000 ± 13.375 45.083 ± 19.685 24.917 ± 12.321 51.250 ± 18.344 23.083 ± 11.206 27.167 ± 10.740
15 41.250 ± 18.808 25.250 ± 13.811 18.750 ± 17.236 39.667 ± 17.751 35.333 ± 11.543 23.500 ± 11.020
C. Light test

Trace 3 s 30 s
Drug Sal 0.4 SKF 0.8 SKF Sal 0.4 SKF 0.8 SKF
Min
1 194.222 ± 36.321 219.400 ± 30.768 202.000 ± 29.447 222.600 ± 20.647 169.167 ± 28.812 212.545 ± 30.884
2 188.000 ± 33.042 231.400 ± 20.749 179.900 ± 29.531 209.600 ± 14.811 192.833 ± 20.935 185.636 ± 25.594
3 163.222 ± 32.100 233.700 ± 24.281 172.400 ± 23.865 185.200 ± 22.719 165.833 ± 19.908 166.364 ± 18.960
4 164.333 ± 33.067 196.100 ± 21.714 162.600 ± 29.847 157.700 ± 20.087 138.500 ± 27.366 146.727 ± 32.314
5 120.667 ± 33.384 131.500 ± 31.680 146.900 ± 22.000 153.300 ± 29.088 161.000 ± 18.989 153.091 ± 21.918
6 107.000 ± 33.872 118.100 ± 27.533 123.900 ± 23.624 150.800 ± 26.368 124.000 ± 16.642 58.455 ± 18.216
7 132.778 ± 33.168 117.300 ± 17.989 77.100 ± 31.154 148.200 ± 20.672 47.167 ± 18.253 67.455 ± 24.309
8 126.000 ± 34.137 120.900 ± 26.409 75.300 ± 23.321 63.400 ± 28.637 85.833 ± 25.531 102.091 ± 26.361
9 57.333 ± 24.927 49.400 ± 14.741 90.500 ± 25.976 68.100 ± 21.420 72.250 ± 23.573 91.545 ± 28.232
10 47.111 ± 27.504 42.000 ± 19.693 47.600 ± 21.662 47.800 ± 23.056 39.833 ± 11.458 20.182 ± 9.571
11 52.889 ± 20.402 25.400 ± 11.294 34.200 ± 16.817 40.100 ± 26.116 29.833 ± 11.971 37.909 ± 20.212
12 60.667 ± 19.857 50.400 ± 27.414 13.900 ± 8.093 24.000 ± 16.277 17.750 ± 12.389 10.455 ± 8.388
13 50.444 ± 25.868 18.600 ± 11.768 31.000 ± 14.844 43.200 ± 13.670 29.750 ± 13.005 37.636 ± 21.417
14 27.333 ± 15.408 25.100 ± 17.642 28.000 ± 9.843 30.400 ± 12.317 17.667 ± 12.579 9.545 ± 5.808
15 104.667 ± 34.721 31.800 ± 18.587 59.100 ± 15.959 61.400 ± 22.952 31.667 ± 14.159 42.364 ± 18.037

3.1.3. CER test—noise CS

There was a main effect of trace on the suppression ratio measure, F(1,66) = 35.099, p < 0.0001, because licking behaviour in rats conditioned with a 30-s trace was less suppressed than licking behaviour in rats conditioned with a 3-s trace interval (Fig. 1B). There was no effect of drug, F(2,66) = 2.228, p = 0.116, or of the trace × drug interaction, F < 1. There was a main effect of min on the number of licks, F(14,924) = 21.758, p < 0.0001, and, more importantly, an interaction between min and trace, F(14,924) = 7.648, p < 0.0001. Drug was significant only by min in the linear trend, F(2,66) = 3.646, p = 0.031. Once rats were drinking freely, those which had been treated with 0.8 mg/kg SKF81297 showed the steepest drop in drinking over the session (Table 1B). However, there was no effect by drug on the min 1 measure, maximum, F(2,66) = 1.166, p = 0.318. Just as would be expected, there was a main effect of trace, F(1,66) = 33.724, p < 0.001 (Fig. 1C).

3.1.4. CER test—flashing lights background

There was no difference in the suppression ratio scores by trace or drug condition, and there was no interaction between drug and trace, all Fs <1 (Fig. 1D). On the licks measure there was a main effect of min, F(14,784) = 55.579, p < 0.0001, but drinking was independent of prior trace, F(14,784) = 0.697, p = 0.778, and drug treatment, F(28,784) = 0.999, p = 0.468 (Table 1C).

3.2. Experiment 2 with 4 conditioning trials

3.2.1. Pre-conditioning—baseline licking

There were no effects of drug, F(2,63) = 0.996, p = 0.375, or trace condition-to-be, F(1, 63) = 1.868, p = 0.177, on latencies to start drinking on the final pre-conditioning day. This shows that the rats’ drinking was well-matched prior to any conditioning. An ANOVA performed on the number of licks made over the 15-min session showed the expected main effect of min, because the rats drank more at the beginning of the session, F(14, 882) = 103.964, p < 0.001. However, drinking over the session was not moderated by drug, F(28, 882) = 0.748, p = 0.825, or trace condition-to-be, F(14,882) = 1.251, p = 0.232 (data not shown).

3.2.2. Reshaping—contextual conditioning

On the day following conditioning there was no evidence of any effect of drug or trace condition on drinking at the start of the session (Fig. 2A). There was no difference in the drink latencies by drug, F(2,63) = 0.392, p = 0.678, or trace, F(1,63) = 0.732, p = 0.395, and there was no interaction between drug and trace, F(2,63) = 0.725, p = 0.488. The number of licks declined over the course of the 15-min session. Statistically, there was a main effect of min, F(14,882) = 77.385, p < 0.001. However, the pattern of drinking over time was not influenced by drug, F(28,882) = 0.761, p = 0.810, or trace, F(14,882) = 1.396, p = 0.148 (Table 2A).

Fig. 2.

Fig. 2

Effects on conditioning of the D1 receptor agonist SKF81297 at 0 (white columns), 0.4 (grey columns), and 0.8 (black columns) mg/kg in Experiment 2. The error bars show the standard error of the mean (n = 10-12/group). Tests were conducted drug-free after prior conditioning under drug conducted with four CS (noise) → US (0.5 mA shock) pairings, presented using either a 3-s or 30-s trace interval. A. Suppression to the experimental chambers: the level of contextual conditioning is expressed as mean latency to make the first lick (s). B. Conditioned suppression to the noise CS expressed as mean suppression ratio. C. Conditioned suppression to the noise CS measured as the number of licks in the first min of test presentation. D. Conditioned suppression to the light background expressed as the mean suppression ratio.

Table 2.

Licking behaviour over the 15 min sessions conducted at (A) reshaping, (B) the noise test and (C) the light test subsequent to treatment with the D1 receptor agonist SKF81297 (SKF) at 0, 0.4 and 0.8 mg/kg in Experiment 2. The table shows the mean number of licks made in each min ± the standard error of the mean. Tests were conducted drug-free after prior conditioning under drug conducted with four CS (noise) → US (0.5 mA shock) pairings, presented using either a 3 s or 30 s trace interval.

A. Reshaping
Trace 3 s 30 s
Drug Sal 0.4 SKF 0.8 SKF Sal 0.4 SKF 0.8 SKF
Min
1 219.400 ± 23.910 252.417 ± 13.516 232.000 ± 17.219 235.273 ± 15.936 200.333 ± 11.481 217.917 ± 17.219
2 192.500 ± 21.749 194.250 ± 18.844 182.000 ± 20.006 180.545 ± 14.008 158.750 ± 16.068 194.333 ± 20.006
3 126.300 ± 26.559 185.167 ± 21.536 168.000 ± 19.952 170.364 ± 14.154 165.083 ± 18.528 171.417 ± 19.952
4 175.500 ± 21.127 129.000 ± 16.616 172.333 ± 24.838 197.091 ± 14.247 165.667 ± 22.494 145.083 ± 24.838
5 124.000 ± 19.938 119.750 ± 19.353 157.333 ± 24.264 166.909 ± 29.597 137.083 ± 24.548 151.750 ± 24.264
6 133.100 ± 22.213 163.917 ± 32.946 145.667 ± 24.398 116.545 ± 22.739 97.500 ± 23.501 116.083 ± 24.398
7 104.200 ± 30.831 77.833 ± 13.092 110.333 ± 21.970 91.727 ± 26.255 48.417 ± 16.750 87.500 ± 21.970
8 74.500 ± 20.281 83.250 ± 18.257 85.417 ± 20.083 121.000 ± 22.614 89.250 ± 23.736 81.333 ± 20.083
9 68.400 ± 30.518 84.333 ± 25.449 44.250 ± 12.035 88.182 ± 17.317 60.417 ± 24.646 66.000 ± 12.035
10 62.500 ± 25.892 47.000 ± 12.012 71.500 ± 26.719 63.455 ± 18.024 28.083 ± 10.413 36.000 ± 26.719
11 40.000 ± 23.171 45.417 ± 15.109 31.417 ± 10.607 62.273 ± 22.757 33.833 ± 23.514 55.250 ± 10.607
12 62.500 ± 26.705 39.333 ± 18.945 49.250 ± 14.171 31.182 ± 22.946 13.250 ± 12.533 58.917 ± 14.171
13 27.400 ± 12.548 32.500 ± 21.329 15.000 ± 7.638 67.000 ± 26.248 29.000 ± 12.484 36.083 ± 7.638
14 22.500 ± 11.592 28.917 ± 10.344 13.583 ± 6.689 16.364 ± 8.561 35.500 ± 12.203 20.167 ± 9.689
15 14.700 ± 7.727 14.167 ± 7.569 15.167 ± 11.999 14.818 ± 8.396 38.417 ± 22.009 31.167 ± 11.999
B. Noise test

Trace 3 s 30 s
Drug Sal 0.4 SKF 0.8 SKF Sal 0.4 SKF 0.8 SKF
Min
1 30.900 ± 22.637 18.583 ± 19.325 91.500 ± 26.411 155.182 ± 22.637 128.917 ± 19.325 180.333 ± 13.888
2 64.200 ± 16.446 123.333 ± 15.752 131.583 ± 31.135 204.000 ± 16.446 178.750 ± 15.742 213.000 ± 15.521
3 79.800 ± 20.543 146.583 ± 22.970 148.250 ± 22.569 189.455 ± 20.543 211.000 ± 22.970 183.833 ± 19.078
4 114.100 ± 23.953 155.167 ± 25.985 157.167 ± 28.449 191.455 ± 23.953 156.917 ± 25.985 226.667 ± 14.498
5 112.300 ± 19.552 114.250 ± 28.386 162.750 ± 23.111 159.545 ± 19.552 178.333 ± 28.386 151.333 ± 15.539
6 85.900 ± 31.776 121.000 ± 15.562 155.417 ± 27.845 130.545 ± 31.776 136.167 ± 15.562 124.417 ± 22.413
7 90.000 ± 30.834 125.250 ± 24.151 151.750 ± 29.676 91.727 ± 30.834 93.417 ± 24.151 99.083 ± 16.868
8 97.800 ± 24.401 118.750 ± 28.424 122.333 ± 29.080 140.818 ± 24.401 93.833 ± 28.424 62.500 ± 17.506
9 110.100 ± 30.670 50.750 ± 24.243 98.250 ± 17.777 142.091 ± 30.670 89.833 ± 24.243 78.167 ± 20.008
10 69.600 ± 9.663 63.167 ± 19.572 101.333 ± 31.702 63.636 ± 9.663 81.750 ± 19.572 48.000 ± 22.186
11 49.000 ± 17.780 52.083 ± 14.917 73.750 ± 19.429 67.727 ± 17.780 53.417 ± 14.917 55.750 ± 14.402
12 112.500 ± 11.275 66.833 ± 10.637 37.667 ± 9.700 21.000 ± 11.275 60.833 ± 10.637 63.000 ± 24.069
13 61.200 ± 9.478 29.667 ± 16.531 18.500 ± 6.336 42.364 ± 9.478 46.833 ± 16.531 27.083 ± 9.407
14 46.800 ± 15.200 13.917 ± 14.663 23.750 ± 9.634 34.727 ± 45.200 37.667 ± 14.663 31.250 ± 12.688
15 38.200 ± 19.402 12.167 ± 5.699 46.500 ± 20.493 22.182 ± 19.402 25.667 ± 5.699 28.250 ± 17.092
C. Light test
Trace 3 s 30 s
Drug Sal 0.4 SKF 0.8 SKF Sal 0.4 SKF 0.8 SKF
Min
1 213.200 ± 22.637 241.833 ± 19.325 237.417 ± 19.107 246.091 ± 9.051 235.833 ± 14.389 232.833 ± 15.119
2 215.700 ± 16.446 203.500 ± 15.742 202.583 ± 18.311 208.091 ± 14.130 193.250 ± 19.958 233.250 ± 12.792
3 194.600 ± 20.543 182.667 ± 22.970 178.750 ± 24.148 237.909 ± 18.239 202.667 ± 13.380 232.417 ± 14.651
4 152.900 ± 23.953 138.883 ± 25.985 196.250 ± 21.783 195.364 ± 28.447 182.833 ± 31.407 176.083 ± 24.513
5 121.400 ± 19.552 129.167 ± 28.386 173.083 ± 23.324 196.727 ± 23.586 183.333 ± 28.771 172.417 ± 19.967
6 106.000 ± 31.776 143.917 ± 15.562 112.833 ± 16.875 159.727 ± 19.284 146.417 ± 22.854 115.000 ± 23.029
7 80.000 ± 30.834 114.167 ± 24.151 191.083 ± 25.129 168.364 ± 28.907 104.333 ± 23.833 111.000 ± 18.209
8 61.000 ± 24.401 53.520 ± 28.424 87.917 ± 25.031 63.818 ± 24.287 119.833 ± 27.705 65.667 ± 20.280
9 56.700 ± 30.670 83.167 ± 24.243 70.333 ± 19.932 64.364 ± 22.517 120.667 ± 24.911 81.750 ± 16.272
10 27.400 ± 9.663 56.583 ± 19.572 31.667 ± 11.91 76.000 ± 18.875 57.917 ± 21.354 76.917 ± 25.204
11 31.800 ± 17.780 33.500 ± 14.917 72.083 ± 16.419 32.182 ± 11.243 25.500 ± 9.953 39.833 ± 16.540
12 20.500 ± 11.275 29.883 ± 10.637 13.083 ± 7.586 2.091 ± 2.091 29.333 ± 12.306 41.000 ± 11.101
13 19.500 ± 9.478 35.417 ± 16.531 35.750 ± 16.417 19.636 ± 12.228 23.750 ± 10.798 27.000 ± 12.498
14 15.200 ± 15.200 45.667 ± 14.663 20.083 ± 13.376 14.545 ± 8.545 48.083 ± 16.037 38.167 ± 9.898
15 56.400 ± 19.402 8.500 ± 5.699 3.667 ± 2.802 2.727 ± 2.000 57.667 ± 25.104 47.667 ± 18.428

3.2.3. CER test—noise CS

There was a main effect of trace on the suppression ratio, F(1,63) = 43.625, p < 0.001. As expected, rats conditioned with a 30 s trace interval were less suppressed than rats conditioned with a 3 s trace interval (Fig. 2B). However, there was no effect of drug, either overall, F(2,63) = 1.198, p = 0.309, or in interaction with trace, F(2,63) = 2.275, p = 0.111. An ANOVA done to analyse the licks measure showed a main effect of min, F(14,882) = 34.495, p < 0.001. Animals initially drank less, reflecting fear conditioning to the noise CS, but drinking later peaked and then dropped over the course of the 15 min session. There was both an overall effect of trace, F(1,63) = 7.228, p = 0.009, and an interaction between trace and min, F(14,882) = 6.779, p < 0.001, as the difference between the 3-s and 30-s conditioned groups dropped over the course of the session (Table 2B). Moreover, the interaction between drug and min was significant in the linear trend, F(2,63) = 4.252, p = 0.019, as was the three-way interaction, F(2,63) = 3.532, p = 0.035. ANOVA restricted to min 1 drinking showed a main effect of drug, F(2,63) = 4.832, p = 0.011, as well as the expected effect of trace, F(1,63) = 39.843, p = 0.001(Fig. 2C). The main effect of drug seen in min 1 arose because rats previously conditioned under 0.8 mg/kg SKF81297 drank more than those conditioned under 0.4 mg/kg SKF, p = 0.003. However neither of the groups conditioned under SKF81297 was significantly different from saline, smallest p = 0.064, for the 0.8 mg/kg group.

3.2.4. CER test—flashing lights background

There was no difference in the suppression ratios by trace, F(1,63) = 1.258, p = 0.266, or the drug condition, F(2,63) = 0.496, p = 0.611, and there was no interaction between drug and trace, F(2,63) = 1.713, p = 0.188 (Fig. 2D). On the licks measure, ANOVA showed the expected main effect of min, F(14,882) = 104.715, p < 0.001. There were no interactions between min and trace, F(14,882) = 1.144, p = 0.315, or between min and drug, F(28,882) = 0.821, p = 0.731. The three-way interaction was significant, F(28,882) = 1.646, p = 0.019. Inspection of the means (shown in Table 2C) suggests that this may have arisen because of a relatively steeper fall off in drinking in rats conditioned under SKF81297 at the 3-s ISI (compared to their respective saline controls), combined with less of a drop in rats conditioned under SKF81297 at the 30-s ISI (compared to their respective saline controls). However, the three-way interaction was significant in the quadratic rather than the linear trend, F(2.63) = 4.112, p = 0.021, and ANOVA restricted to min 1 showed no effect of drug, both Fs < 1.

3.3. Locomotor activity

The groups were initially well-matched in that in the 30 min preceding any injection there were no differences by drug condition-to-be, maximum F(4,38) = 2.033, p = 0.109, for the interaction with blocks. Then over the next 60 min, systemic administration of SKF81297 increased activity at both doses compared to saline starting 10 min after injection and lasting for the further 50 min test duration (Fig. 3). There was an overall effect of drug, F(2,19) = 9.899, p = 0.001, because rats treated with 0.8 mg/kg SKF81297 were more active than those treated with 0.4 mg/kg (p = 0.006) or saline (p < 0.001). The activity of rats treated with 0.4 mg/kg SKF81297 was not significantly different from that seen in the saline-injected controls (p = 0.251). There was an interaction between blocks and drug, F(10,95) = 5.310, p < 0.001. Follow up analyses showed that this arose because although there was no difference by drug dose in the first 10-min block after injection, F(2,19) = 2.043, p = 0.157, there was an effect of drug in all subsequent 10 min blocks, minimum F(2,19) = 5.832, p = 0.011. Further post hocs confirmed that in blocks 5–9, there was a significant difference between the saline and the 0.8 mg/kg SKF81297-treated rats (p = 0.003 in block 5 and p < 0.001 in block 9). The difference between the saline and 0.4 mg/kg SKF81297-treated rats did not reach significance in any block, though it was marginal in block 5 (p=0.059) and block 6 (p = 0.070).

Fig. 3.

Fig. 3

Effect of systemic injections of SKF81297 on locomotor activity monitored for 60 min post injection (in blocks 5–9). For comparison, blocks 1–3 show habituation to the activity chambers over 30 min prior to injection. The error bars show the standard error of the mean (n = 7–8 rats per group). Asterisks indicate a significant difference as compared to saline: **p < 0.01; ***p < 0.001.

4. Discussion

Trace-dependent conditioning was clearly shown in the present experiments in that while conditioning was relatively strong at the 3-s ISI, it was attenuated at the 30-s ISI. This was shown after two (Experiment 1) or four (Experiment 2) conditioning trials conducted in what was otherwise – as far as possible – the same CER procedure. Contrary to prediction, in neither experiment was there any indication that trace conditioning was attenuated by treatment with 0.4 or 0.8 mg/kg SKF81297.

The expected effect of increased LMA under SKF81297 provides a positive control for the effectiveness of this particular batch of drug (Pezze, Marshall, & Fone, 2015b). Neither was SKF81297 completely without effect in the trace conditioning procedure in that there was some evidence for reduced conditioning (measured as relatively increased min 1 licking) under 0.8 mg/kg SKF81297, seen in Experiment 2 which was conducted with an increased number of conditioning trials. There were also some indications that treatment with SKF81297 moderated (the expression of) contextual conditioning as measured in the pattern of drinking seen in the experimental boxes at reshaping in Experiment 1 or during the light test in Experiment 2. This latter effect is broadly consistent with the results seen after localised micro-infusion of SKF81297 in the anterior cingulate part of the mPFC. However, with the more localised administration and the standard two conditioning trials there was evidence for overall increased conditioning to the experimental background (Pezze, Marshall, Domonkos, & Cassaday, 2016). In the present study, the observed effect was not so systematic. Moreover, there was no effect on suppression to the light background in either direction in Experiment 1 of the present study which used 2 conditioning trials.

With respect to the primary objective of the study, to assess effects on trace conditioning, there was no evidence for any reduction in trace conditioning after D1 receptor stimulation in the CER procedure used in the present study. This result is inconsistent with the effects of 0.4 and 0.8 mg/kg SKF81297 in appetitive trace conditioning (Pezze, Marshall, & Cassaday, 2015). This discrepancy raises the possibility that appetitive versus aversive motivation of the trace conditioning task, in other words the nature of the US, is an important determinant of the susceptibility of trace conditioning to dopaminergic modulation (Cassaday et al., 2005). For example, particular combinations of stimuli do not start out equally effective in conditioning, to the extent that some CS-US relationships are learned more easily than others (Garcia & Koelling, 1966; Shapiro, Jacobs, & LoLordo, 1980). However, with an appropriate adjustment to the ISI, trace-dependent conditioning is robustly demonstrated across a variety of conditioning preparations motivated by different appetitive and aversive USs (Cassaday et al., 2005; Horsley & Cassaday, 2007; Kalmbach et al., 2009; Norman & Cassaday, 2003; Pezze, Marshall, & Cassaday, 2015). Therefore, with the right behavioural parameters, the effects of drugs and lesions on trace conditioning might in principle be expected to hold across different procedural variants. However, given the role of dopaminergic systems in the reinforcement mechanisms underlying conditioning (Bromberg-Martin, Matsumoto & Hikosaka, 2010; Dalley et al., 2002; Feenstra et al., 2001; Horvitz, 2000; Iordanova, 2009; Pezze & Feldon, 2004; Salamone, 1994), such stimulus-reinforcer interactions are likely to influence the susceptibility of associative learning to dopaminergic treatments, as has been found to be the case in latent inhibition procedures (Cassaday & Moran, 2010; Moser, Lister, Hitchcock, & Moran, 2000).

Ideally, we would have compared the effects of SKF81297 (and other DA agonists) using appetitive and aversive USs under directly comparable training conditions. Inevitably, over and above differences which may be attributable to task motivation per se, the task motivation in use has secondary effects on other aspects of the procedure, such as, for example, the number of conditioning trials. CER trace procedures only require two conditioning trials and – as a legal requirement – the number of foot shock US deliveries should be the minimum required to support the required level of associative learning. Appetitive conditioning takes place over many trials, up to over 100 in total (Cassaday et al., 2005; Pezze, Marshall, & Cassaday, 2015), and we found that reliable demonstration of within day learning requires the use of 30 conditioning trials (Pezze, Marshall, & Cassaday, 2015). Therefore the number of conditioning trials cannot in practice be equated between appetitive and aversive procedures. However, trace CER procedures have been conducted using 4 conditioning trials and a lower (0.5 mA) foot shock intensity (Norman & Cassaday, 2003) and – adopting these procedures – the effects of SKF81297 were further examined in Experiment 2 of the present study. However, within the constraints of the UK Animal Scientific Procedures Act 1986 Project Licence (PPL 40/3716), we were unable to establish any effect of SKF81297 on trace fear conditioning using the maximum number of conditioning trials permitted (4 trials conducted at half the standard foot shock intensity). Thus the lack of effect of SKF81297 was confirmed (in so far as we were able to test this) independent of the number and intensity of foot shocks.

Similarly, it is not in practice possible to match temporal aspects of appetitive and aversively motivated procedures because the ISIs suitable for optimal associative learning are different to begin with. We have routinely used a maximum ISI of 10 s in appetitive trace conditioning (Cassaday et al., 2005; Pezze, Marshall, & Cassaday, 2015) compared with 30 s which has been found suitable to detect enhanced trace conditioning in the aversive procedure (Horsley and Cassaday, 2007, Nayak and Cassaday, 2003, Norman and Cassaday, 2003). The typical inter-trial-intervals are also rather longer for foot shock procedures. The fact that foot shocks are not given in quick succession allows the animals time to recover, and the required number of conditioning trials can be accommodated within a 15–25 min conditioning session (Cassaday et al., 2005, Norman and Cassaday, 2003).

The response requirements of appetitively- and aversively-motivated procedures are also different. However, direct effects on response rate are excluded by the lack of any response requirement during conditioning when drug treatments are administered and the use of drug-free tests in the CER procedures of the present study. Moreover, drug effects on response rates are controlled for in appetitive trace conditioning procedures (Cassaday et al., 2005; Pezze, Marshall, & Cassaday, 2015).

Because other DA agonists have previously been investigated using the same CER procedures, direct comparisons can be drawn with previously published studies. In the present study, we saw no evidence for enhanced trace conditioning as has been demonstrated after treatment with amphetamines in the CER procedure and at the 30-s trace interval used in the present experiments (Horsley and Cassaday, 2007, Norman and Cassaday, 2003). Albeit using a longer 60-s trace interval, the DA D4 agonist PD 168,077 was similarly without effect in a CER procedure (Nayak & Cassaday, 2003). Taken together with the findings of the present experiments, this lack of effect with more selective receptor agents would seem to suggest that the overall profile of actions at different DA receptor sub-types and/or noradrenergically-mediated effects may mediate increased trace conditioning with an aversive US. Nonetheless procedural differences beyond motivation are likely to be critical. In a conditioned freezing procedure (the retention of) trace conditioning has been found to be impaired by DA D1 blockade in mPFC (Runyan & Dash, 2004). Moreover, in contrast to the present study, Runyan and Dash (2004) used a procedure designed to minimize contextual associations. We have routinely used an experimental background stimulus, which most likely increases the salience of context as well as providing a measure of contextual conditioning which can be tested in the same way as the CS (Horsley and Cassaday, 2007, Nayak and Cassaday, 2003, Norman and Cassaday, 2003).

We find that effects observed in appetitively-motivated trace conditioning do not simply reproduce in an aversively-motivated CER procedure, despite the fact that the CER procedure in use has previously shown sensitivity to dopaminergic manipulations and within the present experiments there were some signs of drug effects in measures of contextual conditioning, albeit not particularly systematic. The particular sensitivity of the appetitive task variant is consistent with the dominant view that DA mainly signals reward value (Schultz, 2010). Even within this motivational system, the incentive value of the US can affect the profile of sensitivity to different DA receptor agents (Olarte-Sánchez, Valencia-Torres, Cassaday, Bradshaw, & Szabadi, 2013). Such differences will inevitably influence the dose-response function seen with individual compounds. Thus, we cannot exclude the possibility that different doses of SKF81297 would have been more effective in the present procedure, particularly given the results earlier obtained with mPFC infusions of SKF81297 (Pezze, Marshall, & Cassaday, 2015) and SCH23390 (Runyan & Dash, 2004).

We acknowledge that differences in the neural substrates of trace conditioning may relate to a multitude of procedural differences in addition to that of the reinforcers in use. Moreover, it is important to stress that such differences do not preclude the existence of neural substrates which mediate aspects of associative learning, such as trace conditioning, across paradigms. Nonetheless, discrepancies of the kind discussed above constrain the delineation of the neuropharmacological substrates of different facets of associative learning irrespective of task variant. Moreover, at the behavioural level the aim has been to establish general theoretical models of learning. The present data may be taken to suggest that different variants of the relevant learning theories may be needed to account for behaviour in tasks which are motivated aversively vs. appetitively, perhaps by formal inclusion of reinforcement sensitivity theory (Gray and McNaughton, 2000, Gray, 1982).

Finally, given the imperative to refine experimental procedures (Russell & Burch, 1959, Chapter 7), it is increasingly important to acknowledge that while appetitive procedures may be better from an animal welfare perspective, other inevitable differences – likely motivational, but perhaps due to other methodological differences – can change the conclusions to be drawn.

Conflicts of interest

None.

Acknowledgement

This work was supported by the BBSRC (ref. BB/K004980/1).

References

  1. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 2010;68:815–834. doi: 10.1016/j.neuron.2010.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cassaday H.J., Horsley R.R., Norman C. Electrolytic lesions to nucleus accumbens core and shell have dissociable effects on conditioning to discrete and contextual cues in aversive and appetitive procedures respectively. Behavioural Brain Research. 2005;160:222–235. doi: 10.1016/j.bbr.2004.12.012. [DOI] [PubMed] [Google Scholar]
  3. Cassaday H.J., Moran P.M. Latent inhibition and other salience modulation effects: same neural substrates? In: Lubow R.E., Weiner I., editors. Latent inhibition: cognition, neuroscience, applications and schizophrenia. Cambridge University Press; 2010. pp. 342–371. [Google Scholar]
  4. Cassaday H.J., Nelson A.J.D., Pezze M.A. From attention to memory along the dorsal-ventral axis of the medial prefrontal cortex: some methodological considerations. Frontiers in Systems Neuroscience. 2014;8 doi: 10.3389/fnsys.2014.00160. Article 160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cassaday H.J., Shilliam C.S., Marsden C.A. Serotonergic depletion increases conditioned suppression to background stimuli in the rat. Journal of Psychopharmacology. 2001;15:83–92. doi: 10.1177/026988110101500204. [DOI] [PubMed] [Google Scholar]
  6. Da Silva B.M., Bast T., Morris R.G.M. Spatial memory: behavioural determinants of persistence in the watermaze delayed matching-to-place task. Learning & Memory. 2015;21:28–36. doi: 10.1101/lm.032169.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dalley J.W., Chudasama Y., Theobald D.E., Pettifer C.L., Fletcher C.M., Robbins T.W. Nucleus accumbens dopamine and discriminated approach learning: interactive effects of 6-hydroxydopamine lesions and systemic apomorphine administration. Psychopharmacology. 2002;161:425–433. doi: 10.1007/s00213-002-1078-2. [DOI] [PubMed] [Google Scholar]
  8. Domjan M. Effects of the intertrial interval on taste-aversion learning in rats. Physiology & Behavior. 1980;25:117–125. doi: 10.1016/0031-9384(80)90191-2. [DOI] [PubMed] [Google Scholar]
  9. Feenstra M.G.P., Vogel M., Botterblom M.H.A., Joosten R.N.J.M.A., de Bruin J.P.C. Dopamine and noradrenaline efflux in the rat prefrontal cortex after classical aversive conditioning to an auditory cue. European Journal of Neuroscience. 2001;13:1051–1054. doi: 10.1046/j.0953-816x.2001.01471.x. [DOI] [PubMed] [Google Scholar]
  10. Garcia J., Koelling R.A. Relation of cue to consequence in avoidance learning. Psychonomic Sciences. 1966;4:123–124. [Google Scholar]
  11. Genoux D., Haditsch U., Knobloch M., Michalon A., Storm D., Mansuy I.M. Protein phosphatase 1 is a molecular constraint on learning and memory. Nature. 2002;418:970–975. doi: 10.1038/nature00928. [DOI] [PubMed] [Google Scholar]
  12. Gilmartin M.R., Balderston N.L., Helmstetter F.J. Prefrontal cortical regulation of fear learning. Trends in Neurosciences. 2014;37:455–464. doi: 10.1016/j.tins.2014.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:13473–13480. doi: 10.1073/pnas.93.24.13473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gray J.A. Oxford University Press; New York: 1982. The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. [Google Scholar]
  15. Gray J.A., McNaughton N. 2nd ed. Oxford University Press; Oxford: 2000. The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. [Google Scholar]
  16. Grimond-Billa S.K., Norman C., Bennett G.W., Cassaday H.J. Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect. Journal of Psychopharmacology. 2008;22:290–299. doi: 10.1177/0269881106081528. [DOI] [PubMed] [Google Scholar]
  17. Horsley R.R., Cassaday H.J. Methylphenidate can reduce selectivity in associative learning in an aversive trace conditioning task. Journal of Psychopharmacology. 2007;21:492–500. doi: 10.1177/0269881106067381. [DOI] [PubMed] [Google Scholar]
  18. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 2000;96:651–656. doi: 10.1016/s0306-4522(00)00019-1. [DOI] [PubMed] [Google Scholar]
  19. Iordanova M.D. Dopaminergic modulation of appetitive and aversive predictive learning. Reviews in the Neurosciences. 2009;20:383–404. doi: 10.1515/revneuro.2009.20.5-6.383. [DOI] [PubMed] [Google Scholar]
  20. Jones C.A., Brown A.M., Auer D.P., Fone K.C. The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology. 2011;214:269–283. doi: 10.1007/s00213-010-1931-7. [DOI] [PubMed] [Google Scholar]
  21. Kalmbach B.E., Ohyama T., Kreider J.C., Riusech F., Mauk M.D. Interactions between prefrontal cortex and cerebellum revealed by trace eyelid conditioning. Learning & Memory. 2009;16:86–95. doi: 10.1101/lm.1178309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lauzon N.M., Bechard M., Ahmad T., Laviolette S.R. Supra-normal stimulation of dopamine D1 receptors in the prelimbic cortex blocks behavioral expression of both aversive and rewarding associative memories through a cyclic-AMP-dependent signaling pathway. Neuropharmacology. 2013;67:104–114. doi: 10.1016/j.neuropharm.2012.10.029. [DOI] [PubMed] [Google Scholar]
  23. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:13508–13514. doi: 10.1073/pnas.93.24.13508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Moser P.C., Lister S., Hitchcock J., Moran P.M. The pharmacology of latent inhibition in the rat: a review of latent inhibition as an animal model of schizophrenia. Brain Research Reviews. 2000;33:247–282. doi: 10.1016/s0165-0173(00)00026-6. [DOI] [PubMed] [Google Scholar]
  25. Nayak S., Cassaday H.J. The novel dopamine D4 receptor agonist (PD 168,077 maleate): Doses with different effects on locomotor activity are without effect in classical conditioning. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2003;27:441–449. doi: 10.1016/S0278-5846(03)00031-9. [DOI] [PubMed] [Google Scholar]
  26. Nelson A.J.D., Thur K.E., Cassaday H.J. Dopamine D1 receptor involvement in latent inhibition and overshadowing. International Journal of Neuropsychopharmacology. 2012;15:1513–1523. doi: 10.1017/S1461145711001751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nelson A.J.D., Thur K.E., Spicer C., Marsden C.A., Cassaday H.J. Catecholaminergic depletion in nucleus accumbens enhances trace conditioning. Advances in Medical Sciences. 2011;56:71–79. doi: 10.2478/v10039-011-0014-2. [DOI] [PubMed] [Google Scholar]
  28. Norman C., Cassaday H.J. Amphetamine increases aversive conditioning to diffuse contextual stimuli and to a discrete trace stimulus when conditioned at higher footshock intensity. Journal of Psychopharmacology. 2003;17:67–76. doi: 10.1177/0269881103017001701. [DOI] [PubMed] [Google Scholar]
  29. Olarte-Sánchez C.M., Valencia-Torres L., Cassaday H.J., Bradshaw C.M., Szabadi E. Effects of SKF-83566 and haloperidol on performance on progressive-ratio schedules maintained by sucrose and corn oil reinforcement: quantitative analysis using a new model derived from the Mathematical Principles of Reinforcement (MPR) Psychopharmacology. 2013;230:617–630. doi: 10.1007/s00213-013-3189-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pavlov I.P. OUP; London: 1927. Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pezze M.A., Bast T., Feldon J. Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cerebral Cortex. 2003;13:371–380. doi: 10.1093/cercor/13.4.371. [DOI] [PubMed] [Google Scholar]
  32. Pezze M.A., Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Progress in Neurobiology. 2004;74:301–320. doi: 10.1016/j.pneurobio.2004.09.004. [DOI] [PubMed] [Google Scholar]
  33. Pezze M.A., Marshall H.J., Cassaday H.J. Dopaminergic modulation of appetitive trace conditioning: the role of D1 receptors in medial prefrontal cortex. Psychopharmacology. 2015;232:2669–2680. doi: 10.1007/s00213-015-3903-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pezze M.A., Marshall H.J., Domonkos A., Cassaday H.J. Effects of dopamine D1 modulation of the anterior cingulate cortex in a fear conditioning procedure. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2016;65:60–67. doi: 10.1016/j.pnpbp.2015.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pezze M.A., Marshall H.J., Fone K.C.F., Cassaday H.J. Dopamine D1 receptor stimulation modulates the formation and retrieval of novel object recognition memory: role of the prelimbic cortex. European Neuropsychopharmacology. 2015;25:2145–2156. doi: 10.1016/j.euroneuro.2015.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pezze M.A., McGarrity S., Mason R., Fone K.C., Bast T. Too little or too much: both functional inhibition and disinhibition of prefrontal cortex cause impairments in attention and executive function. Journal of Neuroscience. 2014;34:7931–7946. doi: 10.1523/JNEUROSCI.3450-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Runyan J.D., Dash P.K. Intra-medial prefrontal administration of SCH-23390 attenuates ERK phosphorylation and long-term memory for trace fear conditioing in rats. Neurobiology of Learning and Memory. 2004;82:65–70. doi: 10.1016/j.nlm.2004.04.006. [DOI] [PubMed] [Google Scholar]
  38. Russell W.M.S., Burch R.L. Methuen; London: 1959. The principles of humane experimental technique (Chapter 7) [Google Scholar]
  39. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behavioural Brain Research. 1994;61:117–133. doi: 10.1016/0166-4328(94)90153-8. [DOI] [PubMed] [Google Scholar]
  40. Schultz W. Dopamine signals for reward value and risk: basic and recent data. Behavioral Brain Functions. 2010;6:24. doi: 10.1186/1744-9081-6-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shapiro K.L., Jacobs W.J., LoLordo V.M. Stimulus-reinforcer interactions in Pavlovian conditioning of pigeons: implications for selective associations. Animal Learning & Behavior. 1980;8:586–594. [Google Scholar]

RESOURCES